相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa
Yusuke Shimakawa et al.
CLINICAL INFECTIOUS DISEASES (2020)
Relationship between hepatitis B core-related antigen levels and sustained HBeAg seroconversion in patients treated with nucleo(s)tide analogues
Milan J. Sonneveld et al.
JOURNAL OF VIRAL HEPATITIS (2019)
The Role of Hepatitis B Core-Related Antigen
Takako Inoue et al.
GENES (2019)
Hepatitis B infection in the general population of China: a systematic review and meta-analysis
Huai Wang et al.
BMC INFECTIOUS DISEASES (2019)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA
Ya-Yun Liu et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection
L. -Y. Mak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Serum HBV Core-Related Antigen Is a Good Predictor for Spontaneous HBeAg Seroconversion in Chronic Hepatitis B Patients
Guangjun Song et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA
Danny Ka-Ho Wong et al.
LIVER INTERNATIONAL (2017)
Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B
En-Qiang Chen et al.
SCIENTIFIC REPORTS (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
HBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b
Hui Ma et al.
CHINESE MEDICAL JOURNAL (2016)
Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen-positive chronic hepatitis B patients
M. J. H. van Campenhout et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Baseline HBsAg and HBcrAg titres allow peginterferon-based precision medicine' in HBeAg-negative chronic hepatitis B patients
M. Martinot-Peignoux et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study
Jue Liu et al.
LANCET INFECTIOUS DISEASES (2016)
Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B
Natthaya Chuaypen et al.
LIVER INTERNATIONAL (2016)
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D
B. Maasoumy et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Michael Nassal
GUT (2015)
Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B
Akihiro Matsumoto et al.
HEPATOLOGY RESEARCH (2015)
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Aparna Schweitzer et al.
LANCET (2015)
Effects of Entecavir on Hepatitis B Virus Covalently Closed Circular DNA in Hepatitis B e Antigen-Positive Patients with Hepatitis B
Ming Shi et al.
PLOS ONE (2015)
Prediction of Spontaneous HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients During the Immune Clearance Phase
Guangjun Song et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss
Q. Zheng et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Hepatitis B virus infection
Christian Trepo et al.
LANCET (2014)
Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments
Ceen-Ming Tang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance
Hung-Chih Yang et al.
EMERGING MICROBES & INFECTIONS (2014)
Significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of hepatitis B virus re-infection after liver transplantation
Toshihisa Matsuzaki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Correlation Between Serum Hepatitis B Virus Core-Related Antigen and Intrahepatic Covalently Closed Circular DNA in Chronic Hepatitis B Patients
Fumitaka Suzuki et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy
Eiji Tanaka et al.
INTERVIROLOGY (2008)
Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection
Danny Ka-Ho Wong et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
分享论文
